Dose modification for haematological toxicity: a survey of Australian medical oncologists-Reference-Cited by-同舟云学术

Dose modification for haematological toxicity: a survey of Australian medical oncologists

Published:2020-11 Issue:11 Volume:50 Page:1338-1343
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Intern Med J

Author:

Cui Wanyuan¹^ORCID,Shingleton Julia²,Byrne Liesel²,Kelly Aisling²,King Lisa²,Smith Phillipa²,Lewis Craig R.³,Stein Brian N.⁴,Shapiro Jeremy⁵,Karapetis Christos⁶^ORCID,Wong Rachel¹⁷^ORCID

Affiliation:

1. Department of Medical Oncology Eastern Health Melbourne Victoria Australia

2. Cancer Institute NSW Sydney New South Wales Australia

3. Prince of Wales Hospital and University of New South Wales Sydney New South Wales Australia

4. Adelaide Cancer Centre Adelaide South Australia Australia

5. Cabrini Haematology and Oncology Centre Melbourne Victoria Australia

6. Department of Medical Oncology Flinders Medical Centre and Flinders University Adelaide South Australia Australia

7. Eastern Health Clinical School Monash University Melbourne Victoria Australia

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imj.14712

Reference16 articles.

1. Review of therapeutic drug monitoring of anticancer drugs part 1 – Cytotoxics

2. How to calculate the dose of chemotherapy

3. Impact of Chemotherapy Dose Intensity on Cancer Patient Outcomes

4. Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Supportive therapies in the prevention of chemotherapy-induced febrile neutropenia and appropriate use of granulocyte colony-stimulating factors: a Delphi consensus statement;Supportive Care in Cancer;2022-11-05